These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. L-dopa for postencephalitic Parkinsonism. Krasner N; Cornelius JM Br Med J; 1970 Nov; 4(5733):496. PubMed ID: 5481239 [No Abstract] [Full Text] [Related]
8. [Advances in the treatment of parkinsonism]. Dowzenko A Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308 [No Abstract] [Full Text] [Related]
9. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
10. [Study of L-dopa treatment and its principal side effects in aged subjects]. Antonini F; Baroni A; Bucalossi A; Roveyaz L Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357 [No Abstract] [Full Text] [Related]
11. [Long-term treatment of Parkinsonism with L-dopa]. Presthus J; Holmsen R Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916 [No Abstract] [Full Text] [Related]
13. [Long term treatment of a parkinsonism with l-dopa]. Presthus J Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069 [No Abstract] [Full Text] [Related]
14. Long-term treatment of Parkinsonism with L-dopa. Presthus J; Holmsen R Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340 [No Abstract] [Full Text] [Related]
15. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related]
16. L-Dopa treatment in Parkinson's Disease. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
17. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]